BBC
BBC
About Virtus Biotech Clinical Trials ETF
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name...
About Virtus Biotech Clinical Trials ETF
This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 TRAX | First Tracks Biotherapeutics Inc | 1.27% | 18.55K | $649.40K |
 RGNX | REGENXBIO Inc. | 1.22% | 49.13K | $626.41K |
 DFTX | Definium Therapeutics, Inc. | 1.12% | 13.22K | $577.05K |
 MNPR | Monopar Therapeutics Inc. | 1.10% | 5.47K | $565.63K |
 MBX | MBX Biosciences, Inc. Common Stock | 1.08% | 9.22K | $553.33K |
 SLS | SELLAS Life Sciences Group, Inc. | 1.03% | 41.79K | $527.36K |
 APGE | Apogee Therapeutics, Inc. | 0.97% | 3.71K | $495.80K |
 QURE | uniQure N.V. | 0.95% | 11.87K | $487.73K |
 ZBIO | Zenas BioPharma, Inc. | 0.90% | 16.52K | $460.72K |
 JBIO | Jade Biosciences, Inc. | 0.89% | 21.33K | $454.31K |
 SLDB | Solid Biosciences Inc. | 0.87% | 45.83K | $445.43K |
 SANA | Sana Biotechnology, Inc. | 0.87% | 122.09K | $444.41K |
 RCKT | Rocket Pharmaceuticals, Inc. | 0.86% | 118.98K | $442.61K |
 BHVN | Biohaven Ltd. | 0.86% | 29.01K | $440.04K |
 PVLA | Palvella Therapeutics, Inc. | 0.86% | 3.01K | $439.11K |
 DMRA | Damora Therapeutics, Inc. | 0.86% | 15.75K | $440.89K |
 VKTX | Viking Therapeutics, Inc. | 0.85% | 11.38K | $433.84K |
 NRIX | Nurix Therapeutics, Inc. | 0.85% | 19.30K | $438.39K |
 NGNE | Neurogene Inc. | 0.84% | 11.24K | $430.87K |
 MPLT | MapLight Therapeutics, Inc. | 0.84% | 11.79K | $431.23K |
SECTOR HOLDINGS
Healthcare
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
United States
Netherlands
Canada
Ireland
Switzerland
United Kingdom
Singapore
Germany
ChinaSECTOR HOLDINGS
Healthcare Financial Services Cash & OthersASSET ALLOCATION BY REGION
United States Netherlands Canada Ireland Switzerland United Kingdom Singapore Germany ChinaHoldings (Top 20)
TRAX
First Tracks Biotherapeutics Inc
RGNX
REGENXBIO Inc.
DFTX
Definium Therapeutics, Inc.
MNPR
Monopar Therapeutics Inc.
MBX
MBX Biosciences, Inc. Common Stock
SLS
SELLAS Life Sciences Group, Inc.
APGE
Apogee Therapeutics, Inc.
QURE
uniQure N.V.
ZBIO
Zenas BioPharma, Inc.
JBIO
Jade Biosciences, Inc.
SLDB
Solid Biosciences Inc.
SANA
Sana Biotechnology, Inc.
RCKT
Rocket Pharmaceuticals, Inc.
BHVN
Biohaven Ltd.
PVLA
Palvella Therapeutics, Inc.
DMRA
Damora Therapeutics, Inc.
VKTX
Viking Therapeutics, Inc.
NRIX
Nurix Therapeutics, Inc.
NGNE
Neurogene Inc.
MPLT
MapLight Therapeutics, Inc.